The PEG-coated collagen patch Hemopatch® for hemostasis and dural sealing in neurosurgery
| CSF leakage; cranial; dural sealant; hemostasis; neurosurgery; spinal
| Rossmann J, Antunes ACM, Broc GG, Chan DTM, Chen SY, Dea N, Fairhall J, de Andrés Guijarro P, Montano N, Schebesch KM, Timothy J, Yerramneni VK (see acknowledgements for Flunkert S.)
| 2025
| Frontiers in Surgery
|
doi: 10.3389/fsurg.2025.1636372
|
New infant formulas for healthy term infants: A randomized, controlled, double-blind, multicenter, non-inferiority design safety study
| Infants; Fatty acids, Soaps; Adverse events; Anthropometry; Weight gain; Body weight; Metaanalysis
| Fleming SA, Flunkert S, Kvistgaard AS, McGrath J, Glover DK
| 2025
| PlosOne
|
doi.org/10.1371/journal.pone.0336689
|
Systematische Übersichtsarbeit über die individuellen biopsychosozialen Aspekte von Interventionen während einer physiologischen Geburt bei Erstgebärenden
| Hebammenbetreuung; Aromatherapie; Transkutane Elektrische Nervenstimulation; Schmerzwahrnehmung; APGAR-Wert
| Berg T, Flunkert S, Brenner E
| 2025
| Zeitschrift für Geburtshilfe und Neonatologie
|
DOI: 10.1055/a-2506-9511
|
How Lysosomes Keep Us Healthy
| Lysosomes; Lysosomal storage diseases; Enzyme replacement therapy; Substrate reduction therapy; Gene therapy;
| Flunkert S, Hirschmugl T
| 2023
| Frontiers for Young Minds
|
10.3389/frym.2023.1109280
|
In vitro assessment of dietary bioactives for TFEB activation as a possible target to support cognitive and emotional wellbeing
| TFEB; Spermidine; Curcumin; Docosahexaenoic acid; Ellagic acid; Astrocytes; Mood disorders
| Trovo L, Vaucher A, Pan Y, Steiner P, Flunkert S, Fleming SA, Preitner N
| 2023
| Journal of Functional Foods
|
10.1016/j.jff.2023.105855
|
Evaluation of Neuropathological Features in the SOD1-G93A Low Copy Number Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
| Body weight; Muscle phenotype; Muscle strength; Neuroinflammation; Spinal cord; Survival rate.
| Molnar-Kasza A, Hinteregger B, Neddens J, Rabl R, Flunkert S, Hutter-Paier B
| 2021
| Frontiers in Molecular Neuroscience
|
PMID: 34248499
|
Homozygosity of BACHD rats not only causes strong behavioral deficits in young female rats but also a reduced breeding success.
| Behavioral analysis; Breeding success; Homozygosity; Huntington’s disease; Learning and memory; Sex differences.
| Kurat S, Heinrich P, Molnar-Kasza A, Loeffler T, Flunkert S, Hutter-Paier B
| 2021
| Brain Research
|
PMID: 33662341
|
Constant Levels of Tau Phosphorylation in the Brain of htau Mice.
| Alzheimer’s disease; Genetic background; Human tau; Immunofluorescent labelling; Mouse model; Phosphorylation; Progression; Tauopathies.
| Neddens J, Daurer M, Loeffler T, Alzola Aldamizetxebarria S, Flunkert S, Hutter-Paier B
| 2020
| Frontiers in Molecular Neuroscience
|
PMID: 3298268
|
Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer’s disease and related murine models.
| Mouse Models; Hippocampus; Genetically modified animals; Phosphorylation; Alzheimer’s disease; Occipital lobe; Dementia
| Neddens J, Daurer M, Flunkert S, Beutl K, Loeffler T, Walker L, Attems J, Hutter-Paier B
| 2020
| PLoS One
|
PMID: 32645028
|
Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value.
| Neurofilament-light chain; Animal model; Biomarker; Cerebrospinal fluid; Lysosomal storage diseases; Neurodegenerative disease; Plasma; Preclinical research
| Loeffler T, Schilcher I, Flunkert S, Hutter-Paier B
| 2020
| Frontiers in Neuroscience
|
PMID: 32595447
|
Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease.
| Mouse models; Cerebellum; Body weight; Hippocampus; Spleen; Thymus; Macrophages; White blood cells
| Schiffer V, Santiago-Mujika E, Flunkert S, Schmidt S, Farcher M, Loeffler T, Schilcher I, Posch M, Neddens J, Sun Y, Kehr J, Hutter-Paier B
| 2020
| PLoS One
|
PMID: 31929594
|
Hepatic and neuronal phenotype of NPC1-/- mice.
| Cell biology; Molecular biology; Neuroscience; Physiology
| Santiago-Mujica E, Flunkert S, Rabl R, Neddens J, Loeffler T, Hutter-Paier B
| 2019
| Heliyon
|
PMID: 30923761
|
Phosphorylation of different tau sites during progression of Alzheimer’s disease.
| Cingulate; Frontal; Immunofluorescent labeling; Microtubule-associated protein tau; Occipital and temporal cortex; Phosphorylation; Transentorhinal region
| Neddens J, Temmel M, Flunkert S, Kerschbaumer B, Hoeller C, Loeffler T, Niederkofler V, Daum G, Attems J, Hutter-Paier B
| 2018
| Acta Neuropathologica Communications
|
PMID: 29958544
|
SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer’s disease.
| Activated microglia; Aggregation inhibitor; Amyloid-β; Pharmacotherapy; Plaques; SEN1500
| Brunner D, Flunkert S, Neddens J, Duller S, Scopes DIC, Treherne JM, Hutter-Paier B
| 2017
| Neuroscience Letters
|
PMID: 28917978
|
Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice.
| Memory deficits; Motor deficits; Parkinson’s disease; Protein expression; Synucleinopathies; α-Synuclein
| Rabl R, Breitschaedel C, Flunkert S, Duller S, Amschl D, Neddens J, Niederkofler V, Rockenstein E, Masliah E, Roemer H, Hutter-Paier B
| 2017
| BMC Neuroscience
|
PMID: 28143405
|
Quantitative evaluation of orofacial motor function in mice: The pasta gnawing test, a voluntary and stress-free behavior test.
| Amyotrophic lateral sclerosis; Neurodegenerative disease; Niemann-Pick disease; Parkinson’s disease; TDP-43; α-synuclein
| Rabl R, Horvath A, Breitschaedel C, Flunkert S, Roemer H, Hutter-Paier B
| 2016
| Journal of Neuroscience Methods
|
PMID:27746230
|
Neuroinflammation and related neuropathologies in APPPSL mice: further values of this in vivo model of Alzheimer’s disease.
| Hippocampus; Cortex, Alzheimer’s disease; Lipid peroxidation; Amyloid-beta; Aggregation
| Loeffler T, Flunkert S, Havas D, Schweinzer C, Uger M, Windisch M, Steyrer E, Hutter-Paier B
| 2014
| Journal of Neuroinflammation
|
PMID: 24886182
|
Commentary to the recently published review „Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer’s disease” by Li, Evrahimi and Schluesener.
| APP; Alzheimer’s disease; Animal models; Drug trials; Tau
| Windisch M, Flunkert S, Havas D, Hutter-Paier B
| 2013
| Ageing Research Reviews
|
PMID: 23851053
|
Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model.
| Parkinson’s disease; Motor deficits; Phosphorylation; Limbic system; GABAergic interneurons; Glutamatergic principal cells; Ventricular zone; Rostral migratory stream
| Amschl D, Neddens J, Havas D, Flunkert S, Rabl R, Roemer H, Rockenstein E, Masliah E, Windisch M, Hutter-Paier B
| 2013
| BMC Neuroscience
|
PMID: 23302418
|
Elevated Levels of Soluble Total and Hyperphosphorylated Tau Result in Early Behavioral Deficits and Distinct Changes in Brain Pathology in a New Tau Transgenic Mouse Model.
| Memory deficits; Phosphorylation; Tau; Tauopathy; Transgenic mouse model
| Flunkert S, Hierzer M, Loeffler T, Rabl R, Neddens J, Duller S, Schofield EL, Ward MA, Posch M, Jungwirth H, Windisch M, Hutter-Paier B
| 2012
| Neurodegenerative Diseases
|
PMID: 22797329
|
Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer’s disease drug candidates.
| Phosphorylation; Tau; in vitro; SH-SY5Y cells; Kinase inhibitor; Mass spectrometry
| Loeffler T, Flunkert S, Taub N, Schofield EL, Ward MA, Windisch M, Hutter-Paier B
| 2012
| Journal of Molecular Neuroscience
|
PMID: 22351109
|
